Healthcare News and Research

Latest Healthcare News and Research

NIH awards multi-million grant for groundbreaking organ transplantation research

Researchers at the Terasaki Institute for Biomedical Innovation have been awarded a multi-million grant from the National Institutes of Health (NIH) to advance research in organ transplantation and antibody-mediated rejection.

6 Sep 2024

Psychological distress common among healthcare workers after medication errors, study finds

Psychological distress is the most common negative outcome experienced by healthcare professionals after making medication errors, according to a new study from the University of Eastern Finland.

6 Sep 2024

New DELIVER guidelines aim to accelerate nanomedicine development

They're tiny drug-delivery systems 1000 times smaller than a human hair, but while nanomedicines have long been hailed as the future for treating debilitating and life-threatening diseases, their journey from lab to patient has many challenges.

6 Sep 2024

Breakthrough technology detects cancer mutant genes with unprecedented sensitivity

Dr. Min-young Lee and Dr. Sung-gyu Park of the Advanced Bio and Healthcare Materials Research Division at KIMS have developed a technology that can detect cancer mutant genes in blood with the world's highest sensitivity of 0.000000001% based on plasmonic nanomaterials for optical signal amplification.

6 Sep 2024

Study reveals key bacteria for developing personalized probiotics for newborns

Newborn babies have one of three pioneer bacteria in their gut shortly after birth, one of which could be used to develop new personalized infant therapeutic probiotics, researchers show.

6 Sep 2024

Wearable activity trackers show promise in detecting early signals of disease

Fitbit, Apple Watch or Oura ring, wearable technology is in high demand among the health conscious. But beyond measuring heart rates and blood pressure, could fitness trackers be used to test for and effectively screen for disease?

6 Sep 2024

New evidence supports continuous infusion for GI cancers

New research just published online by JNCCN - Journal of the National Comprehensive Cancer Network finds that for many commonly used treatment regimens targeting metastatic gastrointestinal (GI) cancers, such as FOLFOX, FOLFIRI, or FOLFIRINOX, it is possible to administer 5-FU solely through continuous infusion, minus the bolus (quick-delivery via intravenous push) component, without negatively affecting patient outcomes.

6 Sep 2024

Aging immune system fuels cancer growth

A novel study by researchers at the Icahn School of Medicine at Mount Sinai addresses a critical yet under-explored question in cancer research: Why is aging the biggest risk factor for cancer? The study reveals how an aging immune system spurs tumor growth, offering new insights into cancer prevention and treatment, especially for older adults.

6 Sep 2024

Mpox inactivated in 60 seconds with Σ-MM™ & patient friendly collection swab

In the wake of the global Mpox outbreak in non-endemic countries in 2022, the medical community has been searching for safer and more efficient ways to transport and test virus samples, especially from patients in areas with limited biological containment facilities.

From Medical Wire 6 Sep 2024

Researchers make breakthrough in predicting the prognosis of triple-negative breast cancer

Scientists at Huntsman Cancer Institute at the University of Utah (the U), the National Cancer Institute-designated cancer center for the Mountain West, have made a significant breakthrough in predicting the prognosis of triple-negative breast cancer (TNBC), a particularly aggressive disease.

5 Sep 2024

New immune cell 'atlas' may aid in the diagnosis and treatment of children with life-threatening diseases

Researchers at The University of Queensland are developing a comprehensive pediatric immune cell 'atlas' to aid in the diagnosis and treatment of children with life-threatening diseases such as cancer, diabetes and lupus.

5 Sep 2024

RSV vaccine reduces illness and hospitalizations in adults over 60

Vaccination against respiratory syncytial virus for adults over 60 is likely cost-effective by preventing illness, hospitalizations, lost quality of life and deaths, according to new research.

5 Sep 2024

Study explores link between food insecurity, gestational diabetes risk among American Indian and Alaska Native females

Food insecurity, defined as the lack of consistent access to sufficient food for an active, healthy life, has been exacerbated in Tribal communities by systemic anti-indigenous racism, including policies that disrupt traditional food practices and access.

5 Sep 2024

Errors in Deloitte-run Medicaid systems can cost millions and take years to fix

The computer systems run by the consulting giant Deloitte that millions of Americans rely on for Medicaid and other government benefits are prone to errors that can take years and hundreds of millions of dollars to update.

5 Sep 2024

Aficamten improves exercise tolerance in patients with HOCM

Exercise intolerance is often severe among patients with cardiovascular disease and can impose significant limitations on their physical abilities and quality of life. Medications known as cardiac myosin inhibitors (CMIs) are being developed to help patients with hypertrophic obstructive cardiomyopathy (HOCM), a disease in which the heart muscle becomes thickened leading to reduced blood flow out of the heart.

5 Sep 2024

Identifying barriers to effective cardiac rehabilitation

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Cardiac rehabilitation (CR) typically consists of physical activity supplemented with lifestyle modifications, including smoking cessation, adherence to a healthy diet, stress management, medication adherence management, risk factor reduction, psychosocial support, and education.

5 Sep 2024

Genetic testing: A game-changer for healthcare

As genetic sequencing technology becomes more accessible and efficient, researchers have made significant strides in understanding the genetic underpinnings of various diseases. This knowledge has led to a surge in clinical applications of genetic testing, offering hope and improved outcomes for individuals affected by many genetic diseases and disorders.

5 Sep 2024

Bats and birds in Madrid are top carriers of zoonotic pathogens, study reveals

Researchers characterize potential zoonotic pathogens present in fecal samples of urban vertebrate species.

4 Sep 2024

Akebia Therapeutics to present at upcoming investor conferences

Akebia Therapeutics®, Inc., a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that its executives will participate in two investor conferences in September: Wells Fargo Healthcare Conference on September 4-6, 2024 in Boston and H.C. Wainwright 26th Annual Global Investment Conference on September 9-11, 2024 in New York.

From Akebia Therapeutics 4 Sep 2024

APDI provides $200,000 in grants to advance pediatric substance use disorder devices

The Alliance for Pediatric Device Innovation (APDI), a nonprofit consortium led by Children's National Hospital and funded through the Food and Drug Administration (FDA), announces today the recipients of grants totaling $200,000 to advance pediatric medical devices that improve the monitoring, diagnosis or treatment of youth suffering from substance use disorder and addiction.

4 Sep 2024